<?xml version="1.0" encoding="UTF-8"?>
<ReportSnapshot Major="1" Minor="0" Revision="1">
	<CoIDs>
		<CoID Type="RepNo">A0296</CoID>
		<CoID Type="CompanyName">Abaxis Inc</CoID>
		<CoID Type="IRSNo">770213001</CoID>
		<CoID Type="CIKNo">0000881890</CoID>
	</CoIDs>
	<Issues>
		<Issue ID="1" Type="C" Desc="Common Stock" Order="1">
			<IssueID Type="Name">Ordinary Shares</IssueID>
			<IssueID Type="Ticker">ABAX</IssueID>
			<IssueID Type="CUSIP">002567105</IssueID>
			<IssueID Type="ISIN">US0025671050</IssueID>
			<IssueID Type="RIC">ABAX.O</IssueID>
			<IssueID Type="SEDOL">2011550</IssueID>
			<IssueID Type="DisplayRIC">ABAX.OQ</IssueID>
			<IssueID Type="InstrumentPI">287613</IssueID>
			<IssueID Type="QuotePI">7645745</IssueID>
			<Exchange Code="NASD" Country="USA">NASDAQ</Exchange>
		</Issue>
		<Issue ID="2" Type="P" Desc="Preferred Stock" Order="1">
			<IssueID Type="Name">Preference Shares</IssueID>
			<IssueID Type="InstrumentPI">101198986</IssueID>
			<Exchange Code="NA" Country="">Not Available</Exchange>
		</Issue>
		<Issue ID="3" Type="P" Desc="Preferred Stock" Order="2">
			<IssueID Type="Name">Preference Shares</IssueID>
			<IssueID Type="InstrumentPI">101198988</IssueID>
			<Exchange Code="NA" Country="">Not Available</Exchange>
		</Issue>
	</Issues>
	<CoGeneralInfo>
		<CoStatus Code="1">Active</CoStatus>
		<CoType Code="EQU">Equity Issue</CoType>
		<LastModified>2017-08-11</LastModified>
		<LatestAvailableAnnual>2017-03-31</LatestAvailableAnnual>
		<LatestAvailableInterim>2017-06-30</LatestAvailableInterim>
		<Employees LastUpdated="2017-03-31">584</Employees>
		<SharesOut Date="2017-08-07" TotalFloat="21665880.0">22691000.0</SharesOut>
		<CommonShareholders Date="2017-03-31">83</CommonShareholders>
		<ReportingCurrency Code="USD">U.S. Dollars</ReportingCurrency>
		<MostRecentExchange Date="2017-08-22">1.0</MostRecentExchange>
	</CoGeneralInfo>
	<TextInfo>
		<Text Type="Business Summary" lastModified="2016-07-10T23:09:00">Abaxis, Inc. is a developer, manufacturer and marketer of portable blood analysis systems that are used in medical specialties in human or veterinary patient care to provide clinicians with blood constituent measurements. The Company markets and sells its products around the world through independent distributors and direct sales force. The Company's segments are the medical market and the veterinary market. The Company's medical market products include Piccolo chemistry analyzers and consumable products. The Company develops, manufactures and sells the Piccolo Xpress chemistry analyzer for use in human patient care to provide clinicians with blood constituent measurements. The Company's veterinary market product offerings include VetScan chemistry analyzers and veterinary reagent discs, VetScan hematology instruments and related reagent kits, VetScan VSpro specialty analyzers and related consumables, VetScan i-STAT analyzers and related consumables and VetScan rapid tests.</Text>
		<Text Type="Financial Summary" lastModified="2017-08-11T10:06:39">BRIEF: For the three months ended 30 June 2017, Abaxis Inc revenues increased 1% to $58.3M. Net income decreased 8% to $6.3M. Revenues reflect Veterinary Market segment increase of 1% to $48.4M, Other segment increase of 18% to $1M, Asia pacific and rest of the world segment increase of 16% to $3M, North America segment increase of less than 1% to $47M. Net income was offset by Research and development - other increase of 22% to $5.7M (expense).</Text>
	</TextInfo>
	<contactInfo lastUpdated="2017-08-11T10:07:01">
		<streetAddress line="1">3240 Whipple Rd</streetAddress>
		<streetAddress line="2"></streetAddress>
		<streetAddress line="3"></streetAddress>
		<city>UNION CITY</city>
		<state-region>CA</state-region>
		<postalCode>94587-1217</postalCode>
		<country code="USA">United States</country>
		<contactName></contactName>
		<contactTitle></contactTitle>
		<phone>
			<phone type="mainphone">
				<countryPhoneCode>1</countryPhoneCode>
				<city-areacode>510</city-areacode>
				<number>6756500</number>
			</phone>
			<phone type="mainfax">
				<countryPhoneCode>1</countryPhoneCode>
				<city-areacode>510</city-areacode>
				<number>4416150</number>
			</phone>
		</phone>
	</contactInfo>
	<webLinks lastUpdated="2016-05-27T11:31:00"><webSite mainCategory="Home Page">http://www.abaxis.com/</webSite><eMail mainCategory="Company Contact/E-mail">investors@abaxis.com</eMail></webLinks>
	<peerInfo lastUpdated="2017-08-11T10:07:01">
		<IndustryInfo>
			<Industry type="TRBC" order="1" reported="0" code="5610101010" mnem="">Advanced Medical Equipment &amp; Technology - NEC</Industry>
			<Industry type="NAICS" order="1" reported="0" code="334510" mnem="">Electromedical and Electrotherapeutic Apparatus Manufacturing</Industry>
			<Industry type="NAICS" order="2" reported="0" code="54194" mnem="">Veterinary Services</Industry>
			<Industry type="NAICS" order="3" reported="0" code="325412" mnem="">Pharmaceutical Preparation  Manufacturing</Industry>
			<Industry type="SIC" order="0" reported="1" code="3829" mnem="">Measuring/controlling Devices Nec</Industry>
			<Industry type="SIC" order="1" reported="0" code="3845" mnem="">Electromedical Equipment</Industry>
			<Industry type="SIC" order="2" reported="0" code="0742" mnem="">Veterinary Services, Specialties</Industry>
			<Industry type="SIC" order="3" reported="0" code="2834" mnem="">Pharmaceutical Preparations</Industry>
		</IndustryInfo>
		<Indexconstituet>S&amp;P 600 Small Cap</Indexconstituet>
	</peerInfo>
	<officers>
		<officer rank="1" since="06/1996">
			<firstName>Clinton</firstName>
			<mI>H.</mI>
			<lastName>Severson</lastName>
			<age>68 </age>
			<title startYear="2015" startMonth="04" startDay="28" iD1="CHM" abbr1="Chmn." iD2="CEO" abbr2="CEO">Chairman of the Board, Chief Executive Officer</title>
		</officer>
		<officer rank="2" since="10/30/2007">
			<firstName>Donald</firstName>
			<mI>Peter</mI>
			<lastName>Wood</lastName>
			<age>64 </age>
			<title startYear="2015" startMonth="04" startDay="28" iD1="PRE" abbr1="Pres." iD2="COO" abbr2="COO">President, Chief Operating Officer</title>
		</officer>
		<officer rank="3" since="10/23/2014">
			<firstName>Ross</firstName>
			<mI></mI>
			<lastName>Taylor</lastName>
			<age>53 </age>
			<title startYear="2015" startMonth="08" startDay="" iD1="CFO" abbr1="CFO" iD2="VFN" abbr2="VP-Fin.">Chief Financial Officer, Vice President - Finance, Secretary</title>
		</officer>
		<officer rank="4" since="02/2000">
			<firstName>Kenneth</firstName>
			<mI>P.</mI>
			<lastName>Aron</lastName>
			<age>63 </age>
			<title startYear="2008" startMonth="04" startDay="" iD1="CTO" abbr1="CTO" iD2="" abbr2="">Chief Technology Officer</title>
		</officer>
		<officer rank="5" since="04/2014">
			<firstName>Craig</firstName>
			<mI>M.</mI>
			<lastName>Tockman</lastName>
			<age>56 </age>
			<title startYear="2014" startMonth="04" startDay="" iD1="VPR" abbr1="VP" iD2="" abbr2="">Vice President - Animal Health Sales and Marketing for North America</title>
		</officer>
		<officer rank="6" since="2008">
			<firstName>Achim</firstName>
			<mI></mI>
			<lastName>Henkel</lastName>
			<age>58 </age>
			<title startYear="2008" startMonth="" startDay="" iD1="OTH" abbr1="Other" iD2="" abbr2="">Managing Director of Abaxis Europe GmbH</title>
		</officer>
	</officers>
	<Ratios PriceCurrency="USD" ReportingCurrency="USD" ExchangeRate="1.00000" LatestAvailableDate="2017-06-30">
		<Group ID="Price and Volume">
			<Ratio FieldName="NPRICE" Type="N">46.17000</Ratio>
			<Ratio FieldName="NHIG" Type="N">55.95000</Ratio>
			<Ratio FieldName="NLOW" Type="N">44.12000</Ratio>
			<Ratio FieldName="PDATE" Type="D">2017-08-23T00:00:00</Ratio>
			<Ratio FieldName="VOL10DAVG" Type="N">0.09392</Ratio>
			<Ratio FieldName="EV" Type="N">910.23300</Ratio>
		</Group>
		<Group ID="Income Statement">
			<Ratio FieldName="MKTCAP" Type="N">1047.64300</Ratio>
			<Ratio FieldName="TTMREV" Type="N">227.78200</Ratio>
			<Ratio FieldName="TTMEBITD" Type="N">49.80900</Ratio>
			<Ratio FieldName="TTMNIAC" Type="N">32.21900</Ratio>
		</Group>
		<Group ID="Per share data">
			<Ratio FieldName="TTMEPSXCLX" Type="N">1.41487</Ratio>
			<Ratio FieldName="TTMREVPS" Type="N">10.00371</Ratio>
			<Ratio FieldName="QBVPS" Type="N">11.96870</Ratio>
			<Ratio FieldName="QCSHPS" Type="N">6.07676</Ratio>
			<Ratio FieldName="TTMCFSHR" Type="N">1.74890</Ratio>
			<Ratio FieldName="TTMDIVSHR" Type="N">0.54000</Ratio>
		</Group>
		<Group ID="Other Ratios">
			<Ratio FieldName="TTMGROSMGN" Type="N">55.22298</Ratio>
			<Ratio FieldName="TTMROEPCT" Type="N">12.55365</Ratio>
			<Ratio FieldName="TTMPR2REV" Type="N">4.59933</Ratio>
			<Ratio FieldName="PEEXCLXOR" Type="N">32.63197</Ratio>
			<Ratio FieldName="PRICE2BK" Type="N">3.85756</Ratio>
			<Ratio FieldName="Employees" Type="N">584</Ratio>
		</Group>
	</Ratios>
	<ForecastData ConsensusType="Mean" CurFiscalYear="2018" CurFiscalYearEndMonth="3" CurInterimEndCalYear="2017" CurInterimEndMonth="9" EarningsBasis="PRX">
		<Ratio FieldName="ConsRecom" Type="N">
			<Value PeriodType="CURR">3.1</Value>
		</Ratio>
		<Ratio FieldName="TargetPrice" Type="N">
			<Value PeriodType="CURR">47.78570</Value>
		</Ratio>
		<Ratio FieldName="ProjLTGrowthRate" Type="N">
			<Value PeriodType="CURR">5.2730</Value>
		</Ratio>
		<Ratio FieldName="ProjPE" Type="N">
			<Value PeriodType="CURR">40.84395</Value>
		</Ratio>
		<Ratio FieldName="ProjSales" Type="N">
			<Value PeriodType="CURR">240.25860</Value>
		</Ratio>
		<Ratio FieldName="ProjSalesQ" Type="N">
			<Value PeriodType="CURR">61.02610</Value>
		</Ratio>
		<Ratio FieldName="ProjEPS" Type="N">
			<Value PeriodType="CURR">1.13040</Value>
		</Ratio>
		<Ratio FieldName="ProjEPSQ" Type="N">
			<Value PeriodType="CURR">0.27800</Value>
		</Ratio>
		<Ratio FieldName="ProjProfit" Type="N">
			<Value PeriodType="CURR">26.07880</Value>
		</Ratio>
		<Ratio FieldName="ProjDPS" Type="N">
			<Value PeriodType="CURR">0.59500</Value>
		</Ratio>
	</ForecastData>
</ReportSnapshot>
